Your browser doesn't support javascript.
loading
Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.
Matsui, Takeshi; Hamada-Tsutsumi, Susumu; Naito, Yutaka; Nojima, Masanori; Iio, Etsuko; Tamori, Akihiro; Kubo, Shoji; Ide, Tatsuya; Kondo, Yasuteru; Eguchi, Yuichiro; Komori, Atsumasa; Morine, Yuji; Shimada, Mitsuo; Utsunomiya, Tohru; Shirabe, Ken; Kimura, Koichi; Hiasa, Yoichi; Chuaypen, Natthaya; Tangkijvanich, Pisit; Naiki-Ito, Aya; Takahashi, Satoru; Ochiya, Takahiro; Tanaka, Yasuhito.
Afiliação
  • Matsui T; Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Hamada-Tsutsumi S; Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Naito Y; Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Nojima M; Tumor Cell Biology Laboratory, The Francis Crick Institute, London, UK.
  • Iio E; Center for Translational Research, The University of Tokyo, The Institute of Medical Science Hospital, Tokyo, Japan.
  • Tamori A; Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kubo S; Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Ide T; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kondo Y; Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Eguchi Y; Department of Hepatology, Sendai Kousei Hospital, Sendai, Japan.
  • Komori A; Division of Hepatology, Saga Medical School, Saga, Japan.
  • Morine Y; Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
  • Shimada M; Department of Digestive Surgery and Transplantation, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Utsunomiya T; Department of Digestive Surgery and Transplantation, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Shirabe K; Department of Surgery, Oita Prefectural Hospital, Oita, Japan.
  • Kimura K; Department of Hepatobiliary and Pancreatic Surgery, Gunma University, Gunma, Japan.
  • Hiasa Y; Department of Surgery and Science, Kyushu University, Fukuoka, Japan.
  • Chuaypen N; Department of Gastroenterology and Metabology, Ehime University, Matsuyama, Japan.
  • Tangkijvanich P; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Naiki-Ito A; Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Takahashi S; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Ochiya T; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Tanaka Y; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
Hepatol Res ; 52(1): 93-104, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34038612
ABSTRACT

AIM:

The microRNA (miR) clusters miR-183/96/182 and miR-217/216a/216b are significantly upregulated in nonviral hepatocellular carcinoma (NBNC-HCC). Here, we investigate the impact of each member of these clusters on the clinical outcome of NBNC-HCC and analyze the antitumor effects of miR-96-5p.

METHODS:

The association between recurrence-free survival of 111 NBNC-HCC patients and the levels of miR-183-5p, miR-96-5p, miR-182-5p, miR-217-5p, miR-216a-5p, and miR-216b-5p in tumor and adjacent tissues was investigated. The impact of miR-96-5p on apoptosis and invasion of a hepatoma cell line, HepG2, was investigated by cell counting, Transwell assay, and flow cytometry, respectively.

RESULTS:

MicroRNA-183-5p, miR-96-5p, miR-182-5p, miR-217-5p, and miR-216b-5p were significantly upregulated in tumor tissues compared to the adjacent tissues (p = 0.0005, p = 0.0030, p = 0.0002, p = 0.0011, and p = 0.0288, respectively). By multivariate Cox regression analysis, high tumor/adjacent ratios of miR-182-5p (p = 0.007) and miR-217-5p (p = 0.008) were associated with poor recurrence-free survival. In contrast, a low tumor/adjacent ratio of miR-96-5p (p < 0.001) was associated with poor recurrence-free survival. It suggested that further upregulation of miR-96-5p in tumors might have an inhibitory effect on recurrence. Transfection of miR-96-5p mimic significantly induced apoptosis of HepG2 cells, in association with downregulation of Nucleophosmin 1 (NPM1) and a decrease of phosphorylated AKT protein. Interestingly, simultaneous knockdown of the NPM1 and AKT genes induced apoptosis. MicroRNA-96-5p also suppressed proliferation and invasion, which inhibited epithelial-to-mesenchymal transition of HCC cells.

CONCLUSION:

MicroRNA-96-5p as a tumor suppressor would be valuable to stratify NBNC-HCC patients at high risk of recurrence.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
...